Mapping Subcortical Brain Alterations in 22q11.2 Deletion Syndrome: Effects of Deletion Size and Convergence With Idiopathic Neuropsychiatric Illness
- PMID: 32046535
- PMCID: PMC7419015
- DOI: 10.1176/appi.ajp.2019.19060583
Mapping Subcortical Brain Alterations in 22q11.2 Deletion Syndrome: Effects of Deletion Size and Convergence With Idiopathic Neuropsychiatric Illness
Abstract
Objective: 22q11.2 deletion syndrome (22q11DS) is among the strongest known genetic risk factors for schizophrenia. Previous studies have reported variable alterations in subcortical brain structures in 22q11DS. To better characterize subcortical alterations in 22q11DS, including modulating effects of clinical and genetic heterogeneity, the authors studied a large multicenter neuroimaging cohort from the ENIGMA 22q11.2 Deletion Syndrome Working Group.
Methods: Subcortical structures were measured using harmonized protocols for gross volume and subcortical shape morphometry in 533 individuals with 22q11DS and 330 matched healthy control subjects (age range, 6-56 years; 49% female).
Results: Compared with the control group, the 22q11DS group showed lower intracranial volume (ICV) and thalamus, putamen, hippocampus, and amygdala volumes and greater lateral ventricle, caudate, and accumbens volumes (Cohen's d values, -0.90 to 0.93). Shape analysis revealed complex differences in the 22q11DS group across all structures. The larger A-D deletion was associated with more extensive shape alterations compared with the smaller A-B deletion. Participants with 22q11DS with psychosis showed lower ICV and hippocampus, amygdala, and thalamus volumes (Cohen's d values, -0.91 to 0.53) compared with participants with 22q11DS without psychosis. Shape analysis revealed lower thickness and surface area across subregions of these structures. Compared with subcortical findings from other neuropsychiatric disorders studied by the ENIGMA consortium, significant convergence was observed between participants with 22q11DS with psychosis and participants with schizophrenia, bipolar disorder, major depressive disorder, and obsessive-compulsive disorder.
Conclusions: In the largest neuroimaging study of 22q11DS to date, the authors found widespread alterations to subcortical brain structures, which were affected by deletion size and psychotic illness. Findings indicate significant overlap between 22q11DS-associated psychosis, idiopathic schizophrenia, and other severe neuropsychiatric illnesses.
Keywords: 22q11.2 Deletion Syndrome; Copy Number Variant; Neuroanatomy; Neurodevelopment; Psychosis; Schizophrenia.
Conflict of interest statement
Disclosures
Declan G. Murphy has received honoraria from Roche. Paul M. Thompson and Christopher R. K. Ching have received grant support from Biogen, Inc. (Boston, USA) for work unrelated to the topic of this manuscript. All other authors have no conflicts of interest to disclose.
Figures




Comment in
-
Subcortical Signatures of Hemizygosity and Psychosis in 22q11.2 Deletion Syndrome: Finding Common Ground in Rare Genetic Variation.Am J Psychiatry. 2020 Jul 1;177(7):564-566. doi: 10.1176/appi.ajp.2020.20050598. Am J Psychiatry. 2020. PMID: 32605438 Free PMC article. No abstract available.
Similar articles
-
Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size.Mol Psychiatry. 2020 Aug;25(8):1822-1834. doi: 10.1038/s41380-018-0078-5. Epub 2018 Jun 13. Mol Psychiatry. 2020. PMID: 29895892 Free PMC article.
-
Positive psychotic symptoms are associated with divergent developmental trajectories of hippocampal volume during late adolescence in patients with 22q11DS.Mol Psychiatry. 2020 Nov;25(11):2844-2859. doi: 10.1038/s41380-019-0443-z. Epub 2019 Jun 4. Mol Psychiatry. 2020. PMID: 31164700
-
Smaller subcortical volumes and enlarged lateral ventricles are associated with higher global functioning in young adults with 22q11.2 deletion syndrome with prodromal symptoms of schizophrenia.Psychiatry Res. 2021 Jul;301:113979. doi: 10.1016/j.psychres.2021.113979. Epub 2021 May 3. Psychiatry Res. 2021. PMID: 33993037
-
Cross disorder comparisons of brain structure in schizophrenia, bipolar disorder, major depressive disorder, and 22q11.2 deletion syndrome: A review of ENIGMA findings.Psychiatry Clin Neurosci. 2022 May;76(5):140-161. doi: 10.1111/pcn.13337. Epub 2022 Feb 26. Psychiatry Clin Neurosci. 2022. PMID: 35119167 Free PMC article. Review.
-
Long-range dysconnectivity in frontal and midline structures is associated to psychosis in 22q11.2 deletion syndrome.J Neural Transm (Vienna). 2016 Aug;123(8):823-39. doi: 10.1007/s00702-016-1548-z. Epub 2016 Apr 19. J Neural Transm (Vienna). 2016. PMID: 27094177 Review.
Cited by
-
Subcortical brain alterations in carriers of genomic copy number variants.medRxiv [Preprint]. 2023 Feb 22:2023.02.14.23285913. doi: 10.1101/2023.02.14.23285913. medRxiv. 2023. Update in: Am J Psychiatry. 2023 Sep 1;180(9):685-698. doi: 10.1176/appi.ajp.20220304. PMID: 36865328 Free PMC article. Updated. Preprint.
-
Pleiotropy and Cross-Disorder Genetics Among Psychiatric Disorders.Biol Psychiatry. 2021 Jan 1;89(1):20-31. doi: 10.1016/j.biopsych.2020.09.026. Epub 2020 Oct 10. Biol Psychiatry. 2021. PMID: 33131714 Free PMC article. Review.
-
Chemoarchitectural signatures of subcortical shape alterations in generalized epilepsy.Commun Biol. 2024 Aug 20;7(1):1019. doi: 10.1038/s42003-024-06726-0. Commun Biol. 2024. PMID: 39164447 Free PMC article.
-
Source-based morphometry reveals structural brain pattern abnormalities in 22q11.2 deletion syndrome.Hum Brain Mapp. 2024 Jan;45(1):e26553. doi: 10.1002/hbm.26553. Hum Brain Mapp. 2024. PMID: 38224541 Free PMC article.
-
Pathways to understanding psychosis through rare - 22q11.2DS - and common variants.Curr Opin Genet Dev. 2021 Jun;68:35-40. doi: 10.1016/j.gde.2021.01.007. Epub 2021 Feb 8. Curr Opin Genet Dev. 2021. PMID: 33571729 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
- P41 EB015922/EB/NIBIB NIH HHS/United States
- T32 MH073526/MH/NIMH NIH HHS/United States
- U01 MH101719/MH/NIMH NIH HHS/United States
- R01 MH085953/MH/NIMH NIH HHS/United States
- R01 MH111671/MH/NIMH NIH HHS/United States
- R01 MH116147/MH/NIMH NIH HHS/United States
- T32 AG058507/AG/NIA NIH HHS/United States
- U54 EB020403/EB/NIBIB NIH HHS/United States
- R56 AG058854/AG/NIA NIH HHS/United States
- R37 MH085953/MH/NIMH NIH HHS/United States
- R01 MH119185/MH/NIMH NIH HHS/United States
- K01 MH102609/MH/NIMH NIH HHS/United States
- R01 MH064824/MH/NIMH NIH HHS/United States
- R01 MH100900/MH/NIMH NIH HHS/United States
- MR/N026063/1/MRC_/Medical Research Council/United Kingdom
- R01 GM125757/GM/NIGMS NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- U01 MH101723/MH/NIMH NIH HHS/United States
- MR/L010305/1/MRC_/Medical Research Council/United Kingdom
- U01 MH087636/MH/NIMH NIH HHS/United States
- P01 HD070454/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous